Header image

Boehringer Ingelheim mini oral: Unravelling HFpEF – Towards personalization of treatment

Friday, August 15, 2025
3:15 PM - 3:45 PM
Theatrette 3

Details

Prof Coats will present on personalisation of HFpEF treatment - Diagnosis of HFpEF, multiple syndromes, challenges in treatment and variation in responses to HFpEF treatment.


Speaker

Prof Andrew Coats
Cardiologist
Heart Research Institute

Unravelling HFpEF – Towards personalization of treatment

3:15 PM - 3:45 PM

Biography

Professor Coats is an experienced academic leader and entrepreneur with three decades of international experience in four of the world’s top universities. He has over 850 peer-reviewed papers, over 175,000 career citations and an H-Index of 168. He has been named one of the top 1,000 researchers of all time by the Webometrics Ranking of World Universities, and author of more than 20 awarded patents. He has launched two successful spin-out biotechnology companies with capital raises in excess of USD100M and licensing deals of more than USD1Billion. Professor Coats is a fully accredited physician and cardiologist in the UK and Australia, a qualified company director, and a trained and experienced fundraiser. He holds two higher doctorates (DSc, Imperial; DM, Oxon) for separate research areas and has held senior offices in five major Professional Societies, and served as President of the largest specialist society in his field (the Heart Failure Association).
Agenda Item Image
Assoc Prof Adam Nelson
Interventional Cardiologist
Royal Adelaide and Queen Elizabeth Hospitals / University of Adelaide

Unravelling HFpEF – Towards personalization of treatment

3:15 PM - 3:45 PM

Biography

Adam Nelson MBBS MBA/MPH PhD FRACP is an early career interventional cardiologist and clinical trialist appointed at the Royal Adelaide and Queen Elizabeth Hospitals, and clinical academic at the University of Adelaide. He is a clinical lead of national and international trials evaluating emerging cardiometabolic therapies and vaccines.
loading